期刊文献+

蛛网膜下腔出血后脑血管痉挛的研究进展 被引量:3

Research development of cerebral vasospasm following subarachnoid hemorrhage
原文传递
导出
摘要 脑血管痉挛(cerebral vasospasm,CVS)是蛛网膜下腔出血(subaraachnoid hemorrhage,SAH)后一种常见的灾难性的并发症,其所致迟发性缺血性神经功能损害是造成患者致残和死亡的最主要原因.虽经多年研究,但其发病机制至今尚未完全阐明.一氧化氮、内皮素-1、血红蛋白氧化产物及炎症反应均被认为参与致病过程.针对这些发病机制的治疗措施目前仍处于研究阶段,预期会在今后的脑血管痉挛的防治中发挥重要作用. Cerebral vasospasm serves as a severe complication in patients who experience subarachnoid hemorrhage. The following delayed ischemic neurological deficits is the leading preventable cause of death and disability. Despite the potentially devastating consequences of cerebral vasospasm, the mechanisms underlining are incompletely understood. Nitric oxide, endothelin-1, bilirubin oxidation products and inflammation appear to be involved in its pathogenesis. Therapies directed at many of these mechanisms are currently under investigation and hold significant promise for an ultimate solution to this substantial problem.
出处 《国际麻醉学与复苏杂志》 CAS 2010年第4期338-342,共5页 International Journal of Anesthesiology and Resuscitation
基金 北京市委组织部优秀人才培养基金(20031D0300413) 北京市科委科技新星计划项目(2007B74)
关键词 蛛网膜下腔出血 脑血管痉挛 一氧化氮 内皮素 炎症反应 Subarachnoid hemorrhage Cerebral vasospasm Nitric oxide Endothelin-1 Inflammation
  • 相关文献

参考文献21

  • 1Bederson JB,Connolly ES Jr,Batjer HH,et al.Guidelines for the management of aneurysmal subarachnoid hemorrhage a statement for healthcare professionals from a special writing group of the stroke council,american heart association.Stroke,2009,40(3):994-1025.
  • 2Jung CS,luliano BA,Harvey-White J,et al.Association between cerebrospinal fluid levels of asymmetric dimethyl -1 -arginine,an endogenous inhibitor of endothelial nitric oxide synthase,and cerebral vasospasm in a primate model of subarachnoid hemorrhage.Neurosurg,2004,101(5):836-842.
  • 3Masaki T.The endothelin family:an overview.J Cardiovasc Pharmacol,2000,35(4 Suppl 2):S3-S5.
  • 4Juvela S.Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.Neurosurg,2000,92(3):390-400.
  • 5Macdonald RL,Pluta RM,Zhang JH,et al.Cerebral vaaoapasm after subarachnoid hemorrhage:the emerging revolution.Nat ClinPractice:Neurol,2007,3(5):256-263.
  • 6Pyne-Geithman GJ,Morgan CJ,Wagner K,et al.Bilirubin produetion and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage.Cereb Blood Flow Metab,2005,25(8):1070-1077.
  • 7Rothoerl RD,Schebesch KM,Kubitza M,et al.ICAM-1 and VCAMI expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits.Cerebrovasc Dis,2006,22(2-3):143-149.
  • 8Lu H,Shi JX,Chen HL,et al.Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage.Brain Res,2009,1262(3):73-80.
  • 9Findlay JM,Kassell NF,Weir BK,et al.A randomized trial of intraoperative,intracisternal tissue plasminogen activator for the prevention of vasospasm.Neurosurgery,1995,37(1):168-176.
  • 10Yin YH,Wang F,Pan YH,et al.Effects of dose-response oftopical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits.Am J Med Sci,2009,337(2):123-125.

同被引文献26

  • 1李永红,郭科,资晓宏,宋治.脑脊液置换术联合蛛网膜下腔注射小剂量尿激酶治疗蛛网膜下腔出血[J].中南大学学报(医学版),2005,30(2):217-220. 被引量:8
  • 2Clark J, Sharp F. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemor- rhage. J Cereb Blood Flow Metabol, 2006, 26 ( 10 ) : 1223-1233.
  • 3Wurster WL, Pyne-Geithman GJ, Peat IR, et al. Bilirubin oxidation products (BOXes) : synthesis, stability and chemi- cal characteristics. Acta Neurochir Suppl,2008, 104:43-50.
  • 4Lyons MA, Shukla R, Zhang K, et al. Increase of metabolic activity and disruption of normal contractile protein distribution by bilirubin oxidation products in vascular smooth-muscle ceils. J Neurosurg, 2004, 100(3) : 505-511.
  • 5Frykholm P, Andersson JL, Langstrom B, et al. Haemodynam- ic and metabolic disturbances in the acute stage of subarachnoid haemorrhage demonstrated by PET. Acta Neurol Scand,.2004,109(1): 25-32.
  • 6Pyne-Geithman G J, Nair SG, Caudell DN, et al. PKC and Rho in vascular smooth muscle: Activation by BOXes and SAH CSF. Front Biosci, 2008,13: 1526-1534.
  • 7Massett MP, Ungvari Z, Csiszar A, et al. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol, 2002, 283 (6) :2282-2287.
  • 8ho K, Shimomura E, Iwanage T, et al. Essential role of Rho kinase in the Ca2+ sensitization of prostaglandin f2a-induced contraction of rabbit aortae. J Physiol, 2003 , 546 ( 3 ) : 823 -836.
  • 9Hou S, Xu R, Clark JF, et al. Bilirubin oxidation end prod- ucts directly alter K channels important in the regulation of vascular tone. J Cereb Blood Flow Metab, 2011, 31(1) : 102-112.
  • 10Horrigan FT, Heinemann SH, Hoshi T. Heme regulates allos- teric activation of the Slol BK channel. J Gen Physiol, 2005,126(1) :7-21.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部